Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal osteodystrophy--pathogenesis and treatment.

H M Cushner, N D Adams

    The American Journal of the Medical Sciences
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Shunt nephritis from Propionibacterium acnes in a solitary kidney.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Acid and mineral balances and bone in familial proximal renal tubular acidosis.

    Kidney international·2000
    Same author

    Progress toward the total synthesis of bafilomycin A(1): stereoselective synthesis of the C15-C25 subunit by additions of nonracemic allenylzinc reagents to aldehydes.

    Organic letters·2000
    Same author

    Case report: autosomal dominant polycystic kidney disease.

    Connecticut medicine·1996
    Same author

    Going fishing.

    The American journal of medicine·1996
    Same author

    Hemolytic-uremic syndrome without evidence of microangiopathic hemolytic anemia on peripheral blood smear.

    Southern medical journal·1996
    Same journal

    Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

    The American journal of the medical sciences·2026
    Same journal

    In Memoriam: Maurice A. Mufson, MD, MACP.

    The American journal of the medical sciences·2026
    Same journal

    Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

    The American journal of the medical sciences·2026
    Same journal

    Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

    The American journal of the medical sciences·2026
    Same journal

    Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

    The American journal of the medical sciences·2026
    Same journal

    The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

    The American journal of the medical sciences·2026
    See all related articles

    End-stage renal disease causes bone disease, including osteitis fibrosa and osteomalacia, due to altered vitamin D, calcium, phosphorus, and parathyroid hormone metabolism. Treatments for renal osteodystrophy and aluminum-associated osteomalacia are reviewed.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Bone Metabolism

    Background:

    • Histologic bone changes like osteitis fibrosa and osteomalacia are common in end-stage renal disease (ESRD).
    • These bone changes can lead to severe disability in some ESRD patients.
    • Altered metabolism of vitamin D, calcium, phosphorus, and parathyroid hormone (PTH) in renal failure contributes to uremic bone disease.

    Purpose of the Study:

    • To review current theories on the pathogenesis and treatment of renal osteodystrophy.
    • To discuss the clinical presentation, pathogenesis, and treatment of aluminum-associated osteomalacic syndromes in uremia.

    Main Methods:

    • Literature review of pathogenesis and treatment theories for renal osteodystrophy.
    • Review of clinical presentation, pathogenesis, and treatment of aluminum-associated osteomalacia in uremia.

    Related Experiment Videos

    Main Results:

    • Uremic bone disease results from complex metabolic alterations in ESRD.
    • Aluminum accumulation can cause specific osteomalacic syndromes in uremic patients.

    Conclusions:

    • Understanding the pathogenesis of renal osteodystrophy is crucial for effective treatment.
    • Management strategies for uremic bone disease and aluminum-associated osteomalacia are essential for improving patient outcomes.